Fragments of erm(E2), otrA, and aph(6) shorter than 400 bp and producer strain-specific rRNA genes were amplified from various antibiotics. The amount of genetic material and the sizes of amplicons recovered from murine feces after oral administration of a ␤-lactamase-encoding plasmid indicated substantial DNA degradation in the mammalian gastrointestinal tract. These observations imply that antibiotics are no major source for horizontal resistance gene transfer in clinical settings.
between resistance genes found in pathogenic clinical isolates and the resistance determinants in the respective antibiotic producer strains have been reported (1) . Producer strain-specific DNA and fragments of resistance genes in semisynthetic and biotechnologically produced antibiotics for livestock and animal husbandry were detected (2, 22) . Our aims were (i) to screen antimicrobials currently used to treat infections in humans for producer strain-specific ribosomal RNA and resistance genes and (ii) to monitor the fate of orally applied resistance determinants in the mammalian gastrointestinal tract to assess the risk for resistance gene transfer by contaminated antibiotic preparations.
Film tablets or capsules of synthetic or semisynthetic origin and antibiotics of microbial origin (Table 1) were ground in a mortar and analyzed with the double-stranded DNA-specific fluorescent dye Picogreen (Molecular Probes). Quantitation was standardized with lambda phage DNA; fluorescence inhibition was detected by spiking the samples with linear pUC18 DNA. DNA amounts found in preparations of microbial and semisynthetic origin were between 8 ng (kanamycin sulfate) and 1,500 ng per gram of antibiotic (vancomycin; Table 1 ). The synthetic fosfomycin was also positive for DNA. Fungal contaminations or DNA from additives may be a reason. DNase I digestion prevented fluorescence emission in treated antibiotic samples. Picogreen was extremely sensitive to contaminations leading to inhibition of fluorescence (e.g., tetracyclines; Table  1 ).
For characterization of the DNA load, 2 grams of erythromycin, oxytetracycline, streptomycin, teicoplanin, or fosfomycin was resuspended in 20 ml of 1ϫ Tris-EDTA buffer supplemented with sodium dodecyl sulfate and proteinase K. After extraction with cetyltrimethylammonium bromide (18), the supernatant was dialyzed with a CELLUSep H1 dialysis bag (Membrane Filtration Products; cutoff, 15,000 Da). The sample volume was reduced to 2 ml (dialysis bag on hygroscopic silica; Sigma). The DNA was isolated with the Prep A Gene DNA purification kit (Bio-Rad). Producer strain DNA was isolated with cetyltrimethylammonium bromide (Table 2) .
Different amplicon sizes were checked by the primer pairs described in Table 3 . A HotStar Taq PCR protocol (QIAGEN, Germany) was applied with the following modifications: 5 l of template, 10 l of 5ϫ Q-solution, and 0.1 M concentrations of the primers were used in a total volume of 50 l. The annealing temperature was optimized for each target in increments of 1°C from 72°C to the primer-specific melting temperature (5). Sixty amplification cycles were used. The amplicons were analyzed on 1.5% agarose gels, purified with the PCR gel extraction kit (QIAGEN), and sequenced (VBC Genomics, Austria).
Ribosomal RNA genes and fragments of erm(E2) were found in erythromycin ( Table 3 ). The 222-bp erm(E2) amplicon and the 178-bp ribosomal fragment showed 100% and 98.9% homology, respectively, to Saccharopolyspora erythraea sequences. All other sequenced amplicons, which were specific for ribosomal RNA genes of Streptomyces rimosus, Streptomyces griseus, and "Actinoplanes teichomyceticus," as well as otrA and aph (6) sequences, were identical to the corresponding database sequences. TecR resistance (21) in teicoplanin and Streptomyces fradiae-specific sequences in fosfomycin were not detectable ( Table 3 ). The amplicon sizes were between 87 bp [aph (6) ] and 378 bp (otrA). The largest proportion of a resistance determinant was obtained with erm(E2), comprising approximately 20% of the intact gene (Table 3) . Amplicons longer than 400 bp could not be amplified from antibiotic preparations (Ն6 PCRs under various amplification conditions). No full-length resistance gene could be detected (Table  3 ). The DNA isolation procedure did not lead to DNA fragmentation (successful amplification of a 1,103-bp amplicon from antibiotics spiked with 1 g/ml pGFP).
Resistance gene recovery from murine feces. Four female BALB/c mice (Himberg, Austria) were housed separately in single cages. A metal lattice serving as the floor allowed for the collection of feces without any further contact between the animal and its excretions. Different amounts of the ␤-lactamase-containing plasmid pGFP (100 pg, 100 ng, and 100 g in 300 l of Tris buffer, pH 8) were administered to three animals by gavage to avoid plasmid contamination. One animal served as a control. The pGFP-encoded sequence of the green fluorescent protein from Aequorea victoria allowed the exclusion of PCR-positive signals from silent ␤-lactamase genes, which may be present in the fecal flora.
A 343-bp fragment could be amplified from murine feces between 3 and 6 h after gavage application of 100 g of DNA (Fig. 1) . Quantification was performed on the LightCycler by using 1 l template (10 g/ml DNA, purified from feces), the primer pair pGFP13/14, and the Faststart DNA SYBR Green master mix (Roche, Austria) in a total volume of 10 l. After an oral administration of 2.8 ϫ 10 13 copies of pGFP, a total of 1.8 ϫ 10 9 copies could be recovered. A 572-bp fragment retrieved from the same DNA isolation could be amplified only at 3 h after application (data not shown). Fragments corre- sponding to approximately 49% of the intact ␤-lactamase gene and 80% of the coding region for green fluorescent protein could be recovered from feces after the administration of 100 g DNA (Table 3) . Fragments comprising 17% of the intact plasmid were found after passing the murine gastrointestinal tract. The amplification of 735-bp, 851-bp, and 1,103-bp fragments failed. No amplification was achieved with animals treated with 100 pg DNA. The administration of 100 ng resulted in amplicon sizes of 86 bp and 174 bp 3 h after onset (Table 3) . In vivo transformation. Two mice with an ampicillin resistance-negative gut flora were pipette fed with 100 g pGFP for 5 days. A third animal was inoculated with a competent Escherichia coli DH5␣ strain until growth and then treated as described above. No ampicillin-resistant transformants in the feces of the animals were observed within 4 weeks after pGFP administration.
Natural transformation of competent bacteria may be below the detection limit under usually applied laboratory conditions (9, 15) . A low probability for transformation may require higher numbers of bacteria/test animals or extremely long observation periods for a positive result under simulated conditions, but natural microbial ecosystems eventually provide such requirements (4, 9, 17) . Long-time exposure to resistance genes by contaminated antibiotics used as feed additives in animal husbandry may support horizontal transfer of free DNA (22, 23) . Recently, a report specified the detection of a vancomycin resistance gene cluster in the growth promoter avoparcin (10) . This cluster may have been acquired by enterococci residing in the animal gut from the preparations and transferred to human pathogenic strains (7, 10, 20) . Mosaic genes found in Neisseria meningitidis and Streptococcus pneumoniae (11) imply a potential for functional recombination of resistance gene fragments in an evolutionary time scale and genetic elements like integrons may provide promoter and recombination sites (6, 19) . However, a phylogenetic comparison of resistance genes in producer strains and bacterial pathogens did not provide evidence for a producer strainspecific origin of clinically relevant resistance functions (8) .
Conclusions. The analyzed semisynthetic and microbial antibiotic preparations contain small amounts of producer strainspecific DNA but no full-length resistance genes. Resistance determinants entering the mammalian gastrointestinal tract are lost in large scale, but units up to 49% of the entire gene are transiently and size-dependently detectable in mammalian feces. These results indicate that antibiotic preparations are no CTTGATCCGGCAAACAAACC a Primer nomenclature is as follows: producer strain/amplification target/amplicon number (first digit), primer number (second digit). b Boldface numbers, successful amplification; lightface numbers, no amplification. Numbers in parentheses indicate percentages of amplicon length compared to the full-length gene/gene plus promoter. -, no promoter sequences described.
c Semi-nested PCR was performed, and the primer pair for the second amplicon is indicated. d For pGFP, the first number is the percentage of amplicon length compared to full-length plasmid.
major source for horizontal resistance gene transfer during therapy.
